Avalo Therapeutics, Inc. (AVTX) Earnings
|
Expand Research on AVTX
| Next EPS Date | N/A | EPS Growth Rate | +86.4% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +22.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/7/25 | Q225 | -$1.92 | $0.00 | -$1.92 | N/A | N/A | N/A |  | | Details | |
| 5/13/25 | Q125 | -$1.25 | $0.00 | -$1.25 | N/A | N/A | N/A | | | Details | |
| 8/12/24 | Q224 | -$14.07 | $0.00 | -$14.07 | N/A | N/A | N/A | | | Details | |
| 4/1/24 | Q423 | -$114.00 | N/A | N/A | $1.92M | $1M | N/A | | | Details | |
| 11/15/23 | Q323 | N/A | -$1.10 | N/A | N/A | $1M | N/A | N/A | N/A | ||
11/9/23  |
Q323 | -$0.11 | -$1.10 | +$0.99 | $240K | $1M | N/A | | | Details | |
| 8/10/23 | Q223 | N/A | -$0.80 | N/A | N/A | $500K | N/A | N/A | N/A | ||
| 5/11/23 | Q123 | N/A | -$0.96 | N/A | N/A | $1M | N/A | N/A | N/A |
